Clik here to view.
Everyone Is Suffering from “Anti-aging” Due to Aging or Other Various...
SEOUL, South Korea Anti-aging is the biggest concern and interest for everyone in the world. TL Plastic Surgery can help them to get their youth back in the most effective solution with professional...
View ArticleClik here to view.
Insider Scoop: The Truth About Jaw Reduction in Korean Plastic Surgery
SEOUL, South Korea With millions of plastic surgery clinics who advertise THEY are the best in Korea, it is close to impossible to find a decent clinic with a “good” doctor who actually cares. This...
View ArticleClik here to view.
Mammoplasty Using Implants, Safety Must Come First! TL Plastic Surgery
SEOUL, South Korea As mammoplasty using implants is getting popular, people started to pay more attention to its safety. It’s a complex procedure as it covers not only breast augmentation but also...
View ArticleClik here to view.
Gynesonics Announces Early Completion of Enrollment in the SONATA FDA...
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for treatment of benign uterine conditions, today announced the...
View ArticleClik here to view.
Clinigen Launches Japanese Business to Strengthen Asian Presence
TOKYO Clinigen Group plc (AIM: CLIN, ‘Clinigen’ or ‘the Group’), the global pharmaceuticals and services group, has launched its Japanese business with the opening of an office in Tokyo, Japan. The...
View ArticleClik here to view.
Takeda Showcases Continued Commitment in Hodgkin Lymphoma During 10th...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) will present data on ADCETRIS® (brentuximab vedotin) in Hodgkin lymphoma at the 10th International Symposium on...
View ArticleClik here to view.
Kymab and EpimAb Biotherapeutics Announce Multi-Target, Bispecific Antibody...
CAMBRIDGE, United Kingdom & SHANGHAI Kymab, a leading human monoclonal antibody biopharmaceutical company, and EpimAb Biotherapeutics, an emerging biopharmaceutical company specializing in...
View ArticleClik here to view.
New Data from Reach2HD Trial Presented at American Neurological Association...
MELBOURNE, Australia Prana Biotechnology Ltd (ASX:PBT/NASDAQ:PRAN) is pleased to announce that further analysis of the cognitive results of its Reach2HD trial to treat Huntington Disease was...
View ArticleClik here to view.
Acucela Issues Notice of Resolutions of the Annual Meeting of Shareholders
SEATTLE Acucela Inc. (Tokyo: 4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
世界麻醉师学会联盟(WFSA)签署承诺，以支持患者安全运动到2020年实现零可预防死亡例数的使命
加州尔湾 (美国商业资讯) — 世界麻醉师学会联盟(WFSA)已签署一项行动承诺，宣布其将支持患者安全运动基金会(PSMF)及其在2020年之前杜绝可预防死亡的使命。同时，PSMF正在加入WFSA的SAFE-T（安全麻醉为人人——今天）活动，以促进全球安全及平价麻醉的获取。WFSA将在第五届世界患者安全科技峰会上正式宣布其承诺，此次会议将于2017年2月3-4日在加州达纳点(Dana...
View ArticleClik here to view.
世界麻酔学会連合（WFSA）、患者安全運動の「2020年までの患者死亡の根絶」という使命を支える誓約に署名
米カリフォルニア州アーバイン （ビジネスワイヤ） — 世界麻酔学会連合（WFSA）は、行動への誓約に署名し、患者安全運動財団（PSMF） と、予防可能な死亡を2020年までに根絶するという同財団の使命を支持すると発表しました。同時にPSMFは、世界中で安全かつ求めやすい麻酔へのアクセスを向上させるためのWFSAのSAFE-T（「すべての患者に安全な麻酔を、今日から」、Safe...
View ArticleClik here to view.
Q2ソリューションズがイルミナと提携しコンパニオン診断薬の能力を拡大
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米ノースカロライナ州モリスビル （ビジネスワイヤ） — 世界的な臨床試験ラボサービス組織のQ2ソリューションズは本日、ゲノムに基づくコンパニオン診断薬（CDx）の当社能力を拡大すると発表しました。この拡大は、Q2ソリューションズ –...
View ArticleClik here to view.
Q2 Solutions与 Illumina合作提升伙伴诊断试剂能力
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 北卡罗莱纳州莫里斯维尔 (美国商业资讯)–全球性临床试验实验室服务组织Q2 Solutions今天宣布拓展其基因组伙伴诊断试剂(CDx)能力。此宣布是Q2 Solutions – EA...
View ArticleClik here to view.
First Patient is Enrolled in Global STEMTRA Trial for Traumatic Brain Injury...
MOUNTAIN VIEW, Calif. & TOKYO SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, today announced that the first patient in Japan was enrolled in the...
View ArticleClik here to view.
Intralink-Spine’s Réjuve Treatment Eliminates Low Back Pain
LEXINGTON, Ky. With the continuation of extremely positive clinical results from its early safety and feasibility study in Malaysia, Intralink-Spine, Inc. (ILS) believes the Réjuve System is going...
View ArticleClik here to view.
Astellas Reports First Half FY2016 Financial Results, Revises Fiscal Year...
TOKYO Astellas Pharma Inc. (TOKYO:4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced financial results for the first six months of fiscal year 2016 ending March 31, 2017...
View ArticleClik here to view.
Takeda Reports First Half FY2016 Results and Raises Full Year Profit Guidance
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Strong first half results led by Growth Drivers Underlying Revenue grew +7.4%, led by a +15.3% increase of Takeda’s Growth...
View ArticleClik here to view.
2016年度上期（4‐9月期）の連結業績について当期利益およびEPSの年間予想、実質的なコア・アーニングスのマネジメントガイダンスを上方修正
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： タケダ成長ドライバーが力強い上期実績を牽引 売上収益の実質的な成長は、タケダ成長ドライバー（消化器系疾患領域、オンコロジー、中枢神経系疾患領域、新興国事業）の＋15.3％の伸長により、対前年同期＋7.4％を達成。財務ベースでは、為替影響（△8.6ポイント）や事業等の売却影響（△4.7ポイント）により対前年同期△5.9％...
View ArticleClik here to view.
Acucela Issues Notice of Listing Approval of Kubota Pharmaceutical Holdings
SEATTLE Acucela Inc. (Tokyo:4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
Hoya Reports Second Quarter Results
TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the second quarter ended September 30, 2016. During the quarter, revenue of the HOYA Group decreased 11.8% year on year, to...
View Article